Pacira Biosciences Inc (PCRX)

CapEx to Revenue

0.69%

Quarterly · Period ending:

PCRX logo

PCRX CapEx to Revenue

Latest reported0.69%
PCRX Quarterly CapEx/Revenue (11.94% → 0.69%)
High-resolution chart · PNG

PCRX capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Pacira Biosciences Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
0.6944%
1.5357%
0.1107%
2.1558%
1.4892%
5.0603%
1.1311%
2.4274%
0.8931%
1.697%
0.992%
2.0704%
2.0087%
4.0944%
3.1939%
3.0938%
6.9269%
4.8534%
5.7578%
10.2379%
7.7815%
10.9832%
11.0007%
6.6077%
11.7952%
6.3624%
3.6733%
1.5208%
1.9999%
2.21%
2.3582%
5.3363%
3.1317%
6.9484%
6.419%
8.0478%
7.2673%
5.2192%
6.6967%
5.7143%
12.7341%
10.7722%
13.1621%
15.4373%
22.4944%
15.8396%
11.5094%
9.5028%
12.7701%
10.3868%
10.2071%
20.19%
10.1511%
25.3042%
45.2823%
73.745%
35.3694%
37.1732%
58.6582%
41.6835%
33.0858%
21.5377%
134.5504%
41.902%
49.2962%
8.7166%
9.3371%
11.9415%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.